GLP-1 agonists give an average reduction of HbA1c of 11 mmol/mol in comparison with placebo (11) and SGLT2 inhibitors give an average HbA1c reduction of 7-9 mmol/mol (12)
BPC-157 may offer comparable or superior results at lower cost, though direct comparison studies do not exist
More Moderator: - Amy Chan, Senior Clinical Research Fellow, and Lead of the Academic Practice Unit University of Auckland, and Auckland District Health Board - New Zealand Panellists: - Jane Barratt, Secretary General, International Federation on Ageing - Canada - Gary Finnegan, Editor, Vaccines Today - Ireland - Velisha Perumal-Pillay, Senior lecturer, University of KwaZulu-Natal - South Africa Watch video Digital event video 24 July 2021, 11:00 - 12:30 CEST Readying the global population for self-care: Health literacy in the 2020s More This event will explore the evolution in our understanding of health literacy and identify practical strategies to improve health literacy in community populations
Frequently Asked Questions About Ozempic and Sun Exposure These are the most common questions GLP-1 patients ask about sun safety, answered with current evidence
Is compounded semaglutide legal and as effective as Ozempic or Wegovy
You can't buy it over the counter, online, or without medical oversight